Agonism of CD40 has been shown to activate cross-presenting dendritic cells, re-educate tumor macrophages toward an M1 phenotype, decrease collagen deposition in the tumor stroma, and trigger antitumor T cell responses [32]. The gene discussed is CD40; the disease is neoplasm.